Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort

Mayass El Ayoubi, Pierre Henri Jarreau, Patrick Van Reempts, Marina Cuttini, Monique Kaminski, Jennifer Zeitlin

Research output: Contribution to journal › Article

3 Citations (Scopus)

Abstract

Objective: We investigated the impact of antenatal diagnosis of fetal growth restriction (FGR) on the risks of mortality and morbidity for very preterm infants given actual birthweight percentiles.Methods: Data on 4608 live born infants 24-31 weeks of gestational age (GA) in 10 European regions in 2003 were used to compare in-hospital mortality, bronchopulmonary dysplasia (BPD) and severe neurological morbidity by birthweight percentiles and antenatal diagnosis of FGR. Other covariates were GA, sex, multiplicity, maternal complications, antenatal corticosteroids, birth in a level III center and region.Results: Sixteen percent (n = 728) of all infants and 72%, 30% and 6%, respectively, of those with birthweight percentiles

Original languageEnglish
Pages (from-to)596-601
Number of pages6
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume29
Issue number4
DOIs
Publication statusPublished - Feb 16 2016

Fingerprint

Fetal Development
Prenatal Diagnosis
Premature Infants
Gestational Age
Morbidity
Bronchopulmonary Dysplasia
Mortality
Hospital Mortality
Adrenal Cortex Hormones
Mothers
Parturition

Keywords

  • Birthweight percentile
  • bronchopulmonary dysplasia
  • fetal growth restriction
  • in-hospital mortality
  • preterm infants
  • severe neurological morbidity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cite this

Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort. / El Ayoubi, Mayass; Jarreau, Pierre Henri; Van Reempts, Patrick; Cuttini, Marina; Kaminski, Monique; Zeitlin, Jennifer.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 29, No. 4, 16.02.2016, p. 596-601.

Research output: Contribution to journal › Article

El Ayoubi, M, Jarreau, PH, Van Reempts, P, Cuttini, M, Kaminski, M & Zeitlin, J 2016, 'Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort', Journal of Maternal-Fetal and Neonatal Medicine, vol. 29, no. 4, pp. 596-601. https://doi.org/10.3109/14767058.2015.1012062
El Ayoubi M, Jarreau PH, Van Reempts P, Cuttini M, Kaminski M, Zeitlin J. Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort. Journal of Maternal-Fetal and Neonatal Medicine. 2016 Feb 16;29(4):596-601. https://doi.org/10.3109/14767058.2015.1012062
El Ayoubi, Mayass ; Jarreau, Pierre Henri ; Van Reempts, Patrick ; Cuttini, Marina ; Kaminski, Monique ; Zeitlin, Jennifer. / Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort. In: Journal of Maternal-Fetal and Neonatal Medicine. 2016 ; Vol. 29, No. 4. pp. 596-601.
@article{4569d177b0104a3688f02c104cac34f0,
title = "Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort",
abstract = "Objective: We investigated the impact of antenatal diagnosis of fetal growth restriction (FGR) on the risks of mortality and morbidity for very preterm infants given actual birthweight percentiles.Methods: Data on 4608 live born infants 24-31 weeks of gestational age (GA) in 10 European regions in 2003 were used to compare in-hospital mortality, bronchopulmonary dysplasia (BPD) and severe neurological morbidity by birthweight percentiles and antenatal diagnosis of FGR. Other covariates were GA, sex, multiplicity, maternal complications, antenatal corticosteroids, birth in a level III center and region.Results: Sixteen percent (n = 728) of all infants and 72{\%}, 30{\%} and 6{\%}, respectively, of those with birthweight percentiles",
keywords = "Birthweight percentile, bronchopulmonary dysplasia, fetal growth restriction, in-hospital mortality, preterm infants, severe neurological morbidity",
author = "{El Ayoubi}, Mayass and Jarreau, {Pierre Henri} and {Van Reempts}, Patrick and Marina Cuttini and Monique Kaminski and Jennifer Zeitlin",
year = "2016",
month = "2",
day = "16",
doi = "10.3109/14767058.2015.1012062",
language = "English",
volume = "29",
pages = "596--601",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort

AU - El Ayoubi, Mayass

AU - Jarreau, Pierre Henri

AU - Van Reempts, Patrick

AU - Cuttini, Marina

AU - Kaminski, Monique

AU - Zeitlin, Jennifer

PY - 2016/2/16

Y1 - 2016/2/16

N2 - Objective: We investigated the impact of antenatal diagnosis of fetal growth restriction (FGR) on the risks of mortality and morbidity for very preterm infants given actual birthweight percentiles.Methods: Data on 4608 live born infants 24-31 weeks of gestational age (GA) in 10 European regions in 2003 were used to compare in-hospital mortality, bronchopulmonary dysplasia (BPD) and severe neurological morbidity by birthweight percentiles and antenatal diagnosis of FGR. Other covariates were GA, sex, multiplicity, maternal complications, antenatal corticosteroids, birth in a level III center and region.Results: Sixteen percent (n = 728) of all infants and 72%, 30% and 6%, respectively, of those with birthweight percentiles

AB - Objective: We investigated the impact of antenatal diagnosis of fetal growth restriction (FGR) on the risks of mortality and morbidity for very preterm infants given actual birthweight percentiles.Methods: Data on 4608 live born infants 24-31 weeks of gestational age (GA) in 10 European regions in 2003 were used to compare in-hospital mortality, bronchopulmonary dysplasia (BPD) and severe neurological morbidity by birthweight percentiles and antenatal diagnosis of FGR. Other covariates were GA, sex, multiplicity, maternal complications, antenatal corticosteroids, birth in a level III center and region.Results: Sixteen percent (n = 728) of all infants and 72%, 30% and 6%, respectively, of those with birthweight percentiles

KW - Birthweight percentile

KW - bronchopulmonary dysplasia

KW - fetal growth restriction

KW - in-hospital mortality

KW - preterm infants

KW - severe neurological morbidity

UR - http://www.scopus.com/inward/record.url?scp=84950341729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84950341729&partnerID=8YFLogxK

U2 - 10.3109/14767058.2015.1012062

DO - 10.3109/14767058.2015.1012062

M3 - Article

C2 - 25747950

AN - SCOPUS:84950341729

VL - 29

SP - 596

EP - 601

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 4

ER -

Access to Document